Gene · 3601
Papers2,328
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
421 to 440 of 2,328
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A peptoid interleukin-15 receptor antagonist suppresses inflammation and arthritis in mice. | Clin Transl Immunology | 2022 | 36439637 | PubTator, text mining | PubMed |
| Anti-thymocyte globulin-mediated immunosenescent alterations of T cells in kidney transplant patients. | Clin Transl Immunology | 2022 | 36439636 | PubTator, text mining | PubMed |
| ALT-803 in the treatment of non-muscle-invasive bladder cancer: Preclinical and clinical evidence and translational potential. | Front Immunol | 2022 | 36439125 | PubTator, text mining | PubMed |
| Pharmacogenetics Role of Genetic Variants in Immune-Related Factors: A Systematic Review Focusing on mCRC. | Pharmaceutics | 2022 | 36432658 | PubTator, text mining | PubMed |
| Extracellular Vesicles in Multiple Myeloma-Cracking the Code to a Better Understanding of the Disease. | Cancers (Basel) | 2022 | 36428668 | PubTator, text mining | PubMed |
| Harnessing natural killer cells to develop next-generation cellular immunotherapy. | Chronic Dis Transl Med | 2022 | 36420177 | PubTator, text mining | PubMed |
| Unveiling sex-based differences in Parkinson's disease: a comprehensive meta-analysis of transcriptomic studies. | Biol Sex Differ | 2022 | 36414996 | PubTator, text mining | PubMed |
| The implications of IL-15 trans-presentation on the immune response. | Adv Immunol | 2022 | 36410873 | PubTator, text mining | PubMed |
| Pre-Existing HSV-1 Immunity Enhances Anticancer Efficacy of a Novel Immune-Stimulating Oncolytic Virus. | Viruses | 2022 | 36366425 | PubTator, text mining | PubMed |
| Immune Microenvironment and Immunotherapeutic Management in Virus-Associated Digestive System Tumors. | Int J Mol Sci | 2022 | 36362398 | PubTator, text mining | PubMed |
| Natural Killer Cells Are Key Host Immune Effector Cells Affecting Survival in Autologous Peripheral Blood Hematopoietic Stem Cell Transplantation. | Cells | 2022 | 36359863 | PubTator, text mining | PubMed |
| The Role of TIM-3 and LAG-3 in the Microenvironment and Immunotherapy of Ovarian Cancer. | Biomedicines | 2022 | 36359346 | PubTator, text mining | PubMed |
| Nanoparticle Enhancement of Natural Killer (NK) Cell-Based Immunotherapy. | Cancers (Basel) | 2022 | 36358857 | PubTator, text mining | PubMed |
| Natural killer cells in clinical development as non-engineered, engineered, and combination therapies. | J Hematol Oncol | 2022 | 36348457 | PubTator, text mining | PubMed |
| Three-dimensional microenvironment regulates gene expression, function, and tight junction dynamics of iPSC-derived blood-brain barrier microvessels. | Fluids Barriers CNS | 2022 | 36333694 | PubTator, text mining | PubMed |
| Metabolomic, Lipidomic, Transcriptomic, and Metagenomic Analyses in Mice Exposed to PFOS and Fed Soluble and Insoluble Dietary Fibers. | Environ Health Perspect | 2022 | 36331819 | PubTator, text mining | PubMed |
| Excessive IL-15 promotes cytotoxic CD4 + CD28- T cell-mediated renal injury in lupus nephritis. | Immun Ageing | 2022 | 36320075 | PubTator, text mining | PubMed |
| Immunovirotherapy: The role of antibody based therapeutics combination with oncolytic viruses. | Front Immunol | 2022 | 36311790 | PubTator, text mining | PubMed |
| Altered transcription factor targeting is associated with differential peripheral blood mononuclear cell proportions in sarcoidosis. | Front Immunol | 2022 | 36311769 | PubTator, text mining | PubMed |
| SOT101 induces NK cell cytotoxicity and potentiates antibody-dependent cell cytotoxicity and anti-tumor activity. | Front Immunol | 2022 | 36300122 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3601/papers?page=22